These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20305421)

  • 1. Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma.
    van de Luijtgaarden AC; Flucke UE; van der Graaf WT; de Rooy JW; Bonenkamp HJ; de Geus-Oei LF
    Clin Nucl Med; 2010 Apr; 35(4):271-2. PubMed ID: 20305421
    [No Abstract]   [Full Text] [Related]  

  • 2. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
    Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
    J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paravertebral schwannoma with high uptake of fluorodeoxyglucose on positron emission tomography.
    De Waele M; Carp L; Lauwers P; Hendriks J; De Maeseneer M; Van Schil P; Blockx P
    Acta Chir Belg; 2005; 105(5):537-8. PubMed ID: 16315843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.
    Gabriel M; Erler H; Donnemiller E; Riccabona G
    Nuklearmedizin; 2002 Apr; 41(2):N14-5. PubMed ID: 11989305
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma.
    Azad A; Chong G; Tauro A; Aly A; Tebbutt NC
    Med Oncol; 2010 Jun; 27(2):230-2. PubMed ID: 19296240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfall of (18)F-FDG-PET imaging in oncology: uterine fibromyoma.
    Tripathi M; Khurana A; D'Souza MM; Sharma R
    Hell J Nucl Med; 2009; 12(2):175-6. PubMed ID: 19675878
    [No Abstract]   [Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography imaging in brain tumours: the Western Australia positron emission tomography/cyclotron service experience.
    McCarthy M; Yuan JB; Campbell A; Lenzo NP; Butler-Henderson K
    J Med Imaging Radiat Oncol; 2008 Dec; 52(6):564-9. PubMed ID: 19178630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
    Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H
    World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma.
    Takahashi S; Kuwabara K; Sawafuji M; Akiduki S; Ishizaka A
    Clin Nucl Med; 2008 Aug; 33(8):555-7. PubMed ID: 18645378
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET evaluation of sinonasal papilloma.
    Cohen EG; Baredes S; Zuckier LS; Mirani NM; Liu Y; Ghesani NV
    AJR Am J Roentgenol; 2009 Jul; 193(1):214-7. PubMed ID: 19542416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
    Anthony MP; Khong PL; Zhang J
    AJR Am J Roentgenol; 2009 Dec; 193(6):W523-9. PubMed ID: 19933627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 FDG PET/CT evaluation of sacrococcygeal chordoma.
    Park SA; Kim HS
    Clin Nucl Med; 2008 Dec; 33(12):906-8. PubMed ID: 19033806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.